Browse by year:

Internal Market

PR(08)05: Iceland fails to incorporate legislation concerning veterinary medicinal products


The EFTA Surveillance Authority has decided to deliver a reasoned opinion to Iceland for failure to incorporate Commission Regulation (EC) No 1646/2004 amending Annex I to Council Regulation (EEC) No 2377/90 concerning maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. Council Regulation (EEC) No 2377/90 lays down the procedure for determining maximum residue limits that are to be set for all pharmacologically active substances in veterinary medicinal products intended to be administered to food-producing animals. Maximum residue levels are established after an examination of the safety of residues of the substance concerned for the consumer of foodstuffs of animal origin and the impact of residues on the industrial processing of foodstuffs.

Icelandhad until 28 January 2006 to incorporate the Commission Regulation (EC) No 1646/2004.

Delivering a reasoned opinion is the second stage in infringement proceedings. The EFTA Surveillance Authority could take the matter to the EFTA Court if Iceland fails to take satisfactory measures within two months of the receipt of the reasoned opinion.


For further information, please contact:

Mr. Hallgrímur Ásgeirsson
Director, Internal Market Affairs Directorate
Tel. (+32)(0)2 286 18 60, or 

Ms Patricia González Gálvez
Senior Officer, Internal Market Affairs Directorate
Tel. (+32)(0)2 286 18 75


6 February 2008

Other EEA Institutions

This website is built with Eplica CMS